{{Rsnum
|rsid=6805118
|Gene=ATR
|Chromosome=3
|position=142498074
|Orientation=plus
|GMAF=0.05464
|Gene_s=ATR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 72.6 | 21.2 | 6.2
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 86.1 | 11.9 | 2.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 77.6 | 22.4 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 90.1 | 9.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23844225
|Title=Associations of ATR and CHEK1 Single Nucleotide Polymorphisms with Breast Cancer
|OA=1
}}

{{PMID Auto
|PMID=17010193
|Title=Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}